Literature DB >> 1903928

Phosphonate monoester inhibitors of class A beta-lactamases.

J Rahil1, R F Pratt.   

Abstract

Phosphonate monoesters with the general structure: [formula: see text] are inhibitors of representative class A and class C beta-lactamases. This result extends the range of this type of inhibitor to the class A enzymes. Compounds where X is an electron-withdrawing substituent are better inhibitors than the unsubstituted analogue (X = H), and enzyme inhibition is concerted with stoichiometric release of the substituted phenol. Slow turnover of the phosphonates also occurs. These observations support the proposition that the mechanism of action of these inhibitors involves phosphorylation of the beta-lactamase active site. The inhibitory ability of these phosphonates suggests that the beta-lactamase active site is very effective at stabilizing negatively charged transition states. One of the compounds described also inactivated the Streptomyces R61 D-alanyl-D-alanine carboxypeptidase/transpeptidase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903928      PMCID: PMC1150124          DOI: 10.1042/bj2750793

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Bacterial resistance to beta-lactam antibiotics: crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.5 A resolution.

Authors:  O Herzberg; J Moult
Journal:  Science       Date:  1987-05-08       Impact factor: 47.728

Review 2.  Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications.

Authors:  C C Sanders; W E Sanders
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

3.  Evidence for an oxyanion hole in serine beta-lactamases and DD-peptidases.

Authors:  B P Murphy; R F Pratt
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

4.  Beta-lactamase of Bacillus licheniformis 749/C at 2 A resolution.

Authors:  P C Moews; J R Knox; O Dideberg; P Charlier; J M Frère
Journal:  Proteins       Date:  1990

5.  A spectrophotometric assay of beta-lactamase action on penicillins.

Authors:  S G Waley
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

6.  Inhibition of a class C beta-lactamase by a specific phosphonate monoester.

Authors:  R F Pratt
Journal:  Science       Date:  1989-11-17       Impact factor: 47.728

7.  Kinetics and mechanism of the serine beta-lactamase catalyzed hydrolysis of depsipeptides.

Authors:  C P Govardhan; R F Pratt
Journal:  Biochemistry       Date:  1987-06-16       Impact factor: 3.162

8.  beta-Lactamase-catalyzed hydrolysis of acyclic depsipeptides and acyl transfer to specific amino acid acceptors.

Authors:  R F Pratt; C P Govardhan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Inactivation of the RTEM-1 cysteine beta-lactamase by iodoacetate. The nature of active-site functional groups and comparisons with the native enzyme.

Authors:  A K Knap; R F Pratt
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

10.  The crystal structure of the beta-lactamase of Streptomyces albus G at 0.3 nm resolution.

Authors:  O Dideberg; P Charlier; J P Wéry; P Dehottay; J Dusart; T Erpicum; J M Frère; J M Ghuysen
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

View more
  7 in total

Review 1.  Fragment-based inhibitor discovery against β-lactamase.

Authors:  Derek A Nichols; Adam R Renslo; Yu Chen
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

2.  Inhibition of class D beta-lactamases by acyl phosphates and phosphonates.

Authors:  S A Adediran; Michiyoshi Nukaga; Stéphane Baurin; J-M Frère; R F Pratt
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases.

Authors:  Orville A Pemberton; Priyadarshini Jaishankar; Afroza Akhtar; Jessie L Adams; Lindsey N Shaw; Adam R Renslo; Yu Chen
Journal:  J Med Chem       Date:  2019-09-13       Impact factor: 7.446

Review 4.  Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.

Authors:  Carine Bebrone; Patricia Lassaux; Lionel Vercheval; Jean-Sébastien Sohier; Adrien Jehaes; Eric Sauvage; Moreno Galleni
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

Review 5.  Class D β-lactamases: a reappraisal after five decades.

Authors:  David A Leonard; Robert A Bonomo; Rachel A Powers
Journal:  Acc Chem Res       Date:  2013-07-31       Impact factor: 22.384

6.  Structure-activity relationships in the inhibition of serine beta-lactamases by phosphonic acid derivatives.

Authors:  J Rahil; R F Pratt
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

Review 7.  Development of new drugs for an old target: the penicillin binding proteins.

Authors:  Astrid Zervosen; Eric Sauvage; Jean-Marie Frère; Paulette Charlier; André Luxen
Journal:  Molecules       Date:  2012-10-24       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.